Showing 321 - 340 of 628 results
Guideline Drug Name
Monoclonal Antibody Agents for Alzheimer's Disease - PA, NF Aduhelm (aducanumab-avwa), Kisunla (donanemab-azbt), Leqembi (lecanemab-irmb intravenous solution), Leqembi IQLIK (lecanemab-irmb subcutaneous solution)
Mulpleta (lusutrombopag) Mulpleta (lusutrombopag)
Multiple Sclerosis (MS) Agents - PA, NF Aubagio (teriflunomide), Avonex (interferon beta-1a), Bafiertam (monomethyl fumarate), Betaseron (interferon beta-1b), Briumvi (ublituximab-xiiy), Copaxone (glatiramer acetate), Glatopa (glatiramer acetate), Kesimpta (ofatumumab), Mayzent (siponimod), Plegridy (peginterferon beta-1a), Ponvory (ponesimod), Rebif (interferon beta-1a), Vumerity (diroximel fumarate), Lemtrada (alemtuzumab), Mavenclad (cladribine), Ocrevus (ocrelizumab), Ocrevus Zunovo (ocrelizumab), Tascenso ODT (fingolimod)
Myalept (metreleptin for injection) Myalept (metreleptin for injection)
Myobloc (rimabotulinumtoxin B) Myobloc (rimabotulinumtoxin B)
Myqorzo (aficamten) Myqorzo (aficamten)
Naglazyme (galsulfase injection) Naglazyme (galsulfase injection)
Namzaric (memantine/donepezil) Namzaric (memantine and donepezil hydrochloride)
Nasal Steroids Xhance (fluticasone propionate)
Nascobal (cyanocobalamin) Spray- Non Formulary Nascobal (cyanocobalamin) Spray
Natalizumab Products Tysabri (natalizumab), Tyruko (natalizumab-sztn)
Nemluvio (nemolizumab-ilto) Nemluvio (nemolizumab-ilto)
Nereus (tradipitant) Nereus (tradipitant)
Nerlynx (neratinib) Nerlynx (neratinib)
Neurologic Agents Gralise (gabapentin), Lyrica CR (pregabalin extended-release), Savella (milnacipran), Tonmya (cyclobenzaprine)
New Drug to Market Program - PA New drug to market
Nexavar (sorafenib) Nexavar (sorafenib)
Nexletol (bempedoic acid) and Nexlizet (bempedoic acid-ezetimibe) Nexletol (bempedoic acid), Nexlizet (bempedoic acid-ezetimibe)
Nexviazyme (avalglucosidase alfa-ngpt) Nexviazyme (avalglucosidase alfa-ngpt)
Niktimvo (axatilimab-csfr)- PA, NF Niktimvo (axatilimab-csfr)